Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Inhibitory oligodeoxynucleotides downregulate herpes simplex virus-induced plasmacytoid dendritic cell type I interferon production and modulate cell function.

Peng WM, Yu CF, Allam JP, Oldenburg J, Bieber T, Hoch J, Eis-Hübinger AM, Novak N.

Hum Immunol. 2007 Nov;68(11):879-87.

2.

Plasmacytoid dendritic cells: the key to CpG.

Rothenfusser S, Tuma E, Endres S, Hartmann G.

Hum Immunol. 2002 Dec;63(12):1111-9. Review.

PMID:
12480254
4.
5.
6.

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Fitzgerald-Bocarsly P, Dai J, Singh S.

Cytokine Growth Factor Rev. 2008 Feb;19(1):3-19. doi: 10.1016/j.cytogfr.2007.10.006. Review.

7.

Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides.

Bayik D, Gursel I, Klinman DM.

Pharmacol Res. 2016 Mar;105:216-25. doi: 10.1016/j.phrs.2015.11.010. Review.

PMID:
26779666
8.

Human plasmacytoid dendritic cells: from molecules to intercellular communication network.

Mathan TS, Figdor CG, Buschow SI.

Front Immunol. 2013 Nov 12;4:372. doi: 10.3389/fimmu.2013.00372. Review.

9.

Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic Cells.

Webster B, Assil S, Dreux M.

J Virol. 2016 Oct 28;90(22):10050-10053. Review.

PMID:
27605675
10.

Plasmacytoid Dendritic Cells: Neglected Regulators of the Immune Response to Staphylococcus aureus.

Bekeredjian-Ding I, Greil J, Ammann S, Parcina M.

Front Immunol. 2014 May 23;5:238. doi: 10.3389/fimmu.2014.00238. Review.

Supplemental Content

Support Center